The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
75 reports and counting
Altis Labs Raises $25M Series A for AI Clinical-Trial Endpoints
Altis Labs raised a $25 million Series A co-led by OrbiMed and Qiming Venture Partners USA to expand AI endpoints for oncology clinical trials.
Footprint Raises $25M Series B for AI-Native Risk Operations
Footprint raised a $25 million Series B led by QED Investors to scale its AI operating system for financial-crime risk and compliance.
iPronics Raises $125M Series B for Optical AI Networking
iPronics raised a $125 million Series B co-led by Maverick Silicon and Light Street Capital to scale optical networking for AI data centers.
Thyme Care Closes $125M+ Series E and Establishes Thyme Companies
Thyme Care raised more than $125 million in a Series E led by Morgan Health at a valuation of more than $2 billion and established Thyme Companies to build new oncology businesses.
Arintra Raises $25M Series B for Healthcare Revenue Assurance
Arintra raised a $25 million Series B led by Define Ventures, bringing total funding to $51 million for its autonomous medical-coding platform.
MomentumShift Platform raises $25M Series B at $112M valuation
MomentumShift Platform secures $25M in Series B funding led by Sequoia Capital, reaching $112M valuation as it accelerates growth in the edtech sector.
CatalystBuild Platform raises $25M Series B at $118M valuation
CatalystBuild Platform secures $25M in Series B funding led by Benchmark, reaching $118M valuation as it accelerates growth in the crypto/web3 sector.
Teleskope Raises $25M in Series A
Teleskope, a Cybersecurity company based in Tel Aviv, Israel, has raised $25M in Series A led by Cyberstarts, Glilot Capital Partners.
Clasp raises $25M Series A to revolutionize devtools industry
Clasp secures $25M in Series A funding, reaching $180M valuation to expand its developer tools platform for building and deploying cloud applications.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.